Monoclonal gammopathy of undetermined significanceBLADE, Joan.The New England journal of medicine. 2006, Vol 355, Num 26, pp 2765-2770, issn 0028-4793, 6 p.Article

Treatment approaches for relapsing and refractory multiple myelomaBLADE, Joan; ESTEVE, Jordi.Acta oncologica (Stockholm). 2000, Vol 39, Num 7, pp 843-847, issn 0284-186XConference Paper

Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?BLADE, Joan; MONTOTO, Silvia; ROSINOL, Laura et al.Seminars in oncology. 2003, Vol 30, Num 2, pp 329-331, issn 0093-7754, 3 p.Article

Bortezomib-induced severe hepatitis in multiple myeloma: A case reportROSINOL, Laura; MONTOTO, Silvia; CIBEIRA, Maria Teresa et al.Archives of internal medicine (1960). 2005, Vol 165, Num 4, pp 464-465, issn 0003-9926, 2 p.Article

Synergies between chemical and biotechnological approaches for the synthesis of chiral intermediatesFAUS, Ignacio; DEL RIO, José Luis; CANOVAS, Antonio et al.Chimica oggi. 2000, Vol 18, Num 7-8, pp 9-13, issn 0392-839XArticle

Hematopoietic stem cell transplantation for multiple myeloma beyond 2010BLADE, Joan; ROSINOL, Laura; CIBEIRA, Maria Teresa et al.Blood. 2010, Vol 115, Num 18, pp 3655-3663, issn 0006-4971, 9 p.Article

Smoldering (Asymptomatic) Multiple Myeloma: Current Diagnostic Criteria, New Predictors of Outcome, and Follow-Up RecommendationsBLADE, Joan; DIMOPOULOS, Meletios; ROSINOL, Laura et al.Journal of clinical oncology. 2010, Vol 28, Num 4, pp 690-697, issn 0732-183X, 8 p.Article

Lipase-catalysed synthesis of natural ethanol esters : effect of water removal on enzyme reutilisationDEL RIO, José L; CAMINAL, Gloria; FITE, Mercé et al.Journal of chemical technology and biotechnology (1986). 2000, Vol 75, Num 11, pp 991-996, issn 0268-2575Article

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple MyelomaPALUMBO, Antonio; HAJEK, Roman; CASCAVILLA, Nicola et al.The New England journal of medicine. 2012, Vol 366, Num 19, pp 1759-1769, issn 0028-4793, 11 p.Article

Prognostic Value of Immunophenotyping in Multiple Myeloma : A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose TherapyMATEO, Gema; MONTALBDN, M. Angeles; DE LA RUBIA, Javier et al.Journal of clinical oncology. 2008, Vol 26, Num 16, pp 2737-2744, issn 0732-183X, 8 p.Article

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. CommentaryBARLOGIE, Bart; EPSTEIN, Joshua; MONTEJANO, Laura et al.Blood. 2008, Vol 112, Num 10, issn 0006-4971, 3817-3818, 4017-4023 [9 p.]Article

Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish RegistryALEGRE, Adrian; GRANDA, Asuncion; FERNANDEZ-RANADA, José Maria et al.Haematologica (Roma). 2002, Vol 87, Num 6, pp 609-614, issn 0390-6078Article

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple MyelomaMATEOS, María-Victoria; HERNANDEZ, Miguel-Teodoro; ORIOL, Albert et al.The New England journal of medicine. 2013, Vol 369, Num 5, pp 438-447, issn 0028-4793, 10 p.Article

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trialMATEOS, María-Victoria; ORIOL, Albert; PALOMERA, Luis et al.Blood. 2012, Vol 120, Num 13, pp 2581-2588, issn 0006-4971, 8 p.Article

Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agentsFERNANDEZ DE LARREA, Carlos; TOVAR, Natalia; TERESA CIBEIRA, Maria et al.Haematologica (Roma). 2011, Vol 96, Num 1, pp 171-173, issn 0390-6078, 3 p.Article

Long-term prognostic significance of response in multiple myeloma after stem cell transplantationMARTINEZ-LOPEZ, Joaquin; BLADE, Joan; DE ARRIBA, Felipe et al.Blood. 2011, Vol 118, Num 3, pp 529-534, issn 0006-4971, 6 p.Article

Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenanceMATEOS, María-Victoria; GUTIERREZ, Norma C; DIAZ-MEDIAVILLA, Joaquín et al.Blood. 2011, Vol 118, Num 17, pp 4547-4553, issn 0006-4971, 7 p.Article

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsTERESA CIBEIRA, Maria; SANCHORAWALA, Vaishali; MARK SLOAN, J et al.Blood. 2011, Vol 118, Num 16, pp 4346-4352, issn 0006-4971, 7 p.Article

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)PALUMBO, Antonio; BRINGHEN, Sara; ZWEEGMAN, Sonja et al.Blood. 2011, Vol 118, Num 17, pp 4519-4529, issn 0006-4971, 11 p.Article

Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple MyelomaLUDWIG, Heinz; BOLEJACK, Vanessa; SONNEVELD, Pieter et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1599-1605, issn 0732-183X, 7 p.Article

Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myelomaLONIAL, Sagar; RICHARDSON, Paul G; ANDERSON, Kenneth C et al.British journal of haematology. 2008, Vol 143, Num 2, pp 222-229, issn 0007-1048, 8 p.Article

Thalidomide for treatment of multiple myeloma : 10 years laterPALUMBO, Antonio; FACON, Thierry; BOCCADORO, Mario et al.Blood. 2008, Vol 111, Num 8, pp 3968-3977, issn 0006-4971, 10 p.Article

The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myelomaNIESVIZKY, Ruben; RICHARDSON, Paul G; HAROUSSEAU, Jean-Luc et al.British journal of haematology. 2008, Vol 143, Num 1, pp 46-53, issn 0007-1048, 8 p.Article

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma : results of a multicenter phase 1/2 studyMATEOS, Maria-Victoria; HERNANDEZ, José-M; SUREDA, Ana et al.Blood. 2006, Vol 108, Num 7, pp 2165-2172, issn 0006-4971, 8 p.Article

International staging system for multiple myelomaGREIPP, Philip R; SAN MIGUEL, Jesus; LAHUERTA, Juan J et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3412-3420, issn 0732-183X, 9 p.Article